SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Premaitha Health plc, et al. and the patent infringement suit filed against Ariosa Diagnostics, Inc., et al. The Court found... Read more
opnME.com provides scientists with many best-in-class tool molecules supported by comprehensive data packages on one centralized platform for researchers to use The platform offers direct access to molecules for independent research as well as other molecules for partnering with Boehringer Ingelheim. Ingelheim, Germany – 20 November, 2017 – Boehringer Ingelheim today announced the launch of opnME.com,... Read more
FRANKLIN LAKES, N.J., Nov. 16, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its latest advancement in comprehensive medication management, BD HealthSight™ platform for enterprise medication management, which offers a unique combination of connective technologies, analytics and expert services at this year’s American Society of... Read more
SALT LAKE CITY, Nov. 16, 2017 — Today at the Association for Molecular Pathology’s 2017 Annual Meeting (AMP), Edico Genome announced a new offering: the comprehensive DRAGEN Clinical Genomics Information System (CGIS). Designed to enable clinical laboratories of all sizes to quickly, simply and efficiently develop sequencing-based laboratory developed tests (LDTs), DRAGEN CGIS harnesses the power of... Read more
SALT LAKE CITY, Nov. 16, 2017 — Today at the Association for Molecular Pathology (AMP) 2017 Annual Meeting, Edico Genome announced an affiliation with Children’s Hospital Los Angeles (CHLA). The hospital will utilize Edico Genome’s DRAGENTM Bio-IT platform to deliver enhanced patient care and accelerate research initiatives to expand test offerings for children with genetic disorders and cancer. CHLA... Read more
– Kit expands multiplexing options, allowing more biomarkers to be investigated on a single tissue slide – Multiplexed assays for simultaneously detecting several biomarkers in a single sample address growing need to obtain more information from limited tissue samples TUCSON, Arizona, Nov. 16, 2017 /PRNewswire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the... Read more
First bioinformatics solution integrating new AMP/ASCO/CAP standards for NGS cancer testing to confidently and quickly report clinical relevance of somatic mutations Hilden, Germany, and Germantown, Maryland, November 15, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for... Read more
Hilden, Germany, and Germantown, Maryland, November 15, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer, advancing precision medicine with the first solution to offer molecular pathologists... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today the introduction of its NextSeq™ 550Dx instrument, the company’s second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system. The company also announced that the intended use for the MiSeq™Dx instrument has been updated to include the use of DNA libraries generated from formalin-fixed paraffin embedded (FFPE) tissues,... Read more
Solution enables clinical labs that perform cancer NGS testing to quickly convert genomic insights to targeted therapies November 15, 2017 05:00 AM Pacific Standard Time SALT LAKE CITY–(BUSINESS WIRE)–This week, at the Association for Molecular Pathology (AMP) Annual Meeting, Fabric Genomics will announce its expanded somatic cancer solution which provides seamless genomic analysis and clinical reporting to... Read more